Humoral immune responses to Neisseria meningitidis in children

Infection and Immunity

Volumn 67, Issue 5, 1999, Pages 2441-2451

  Pollard, Andrew J ^a   Galassini, Rachel ^a   Rouppe Van Der Voort, Eileene M ^b   Booy, Robert ^a   Langford, Paul ^a   Nadel, Simon ^a   Ison, Catherine ^a   Kroll, J Simon ^a   Poolman, Jan ^b,c   Levin, Michael ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; SERUM BACTERICIDAL ACTIVITY;

EID: 0032956543     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.5.2441-2451.1999     Document Type: Article

References (60)

1. Abdillahi, H., and J. T. Poolman. 1988. Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA. Microb. Pathog. 4:27-32.
2. Abdillahi, H., and J. T. Poolman. 1988. Typing of group-B Neisseria meningitidis with monoclonal antibodies in the whole-cell ELISA. J. Med. Microbiol. 26:177-180.
3. Amato Neto, V., H. Finger, E. C. Gotschlich, R. A. Feldman, C. A. de Avila, S. R. Konichi, and W. C. Laus. 1974. Serologic response to serogroup C meningococcal vaccine in Brazilian preschool children. Rev. Inst. Med. Trop. Sao Paulo 16:149-153.
4. Baltimore, R. S., and M. Hammerschlag. 1977. Meningococcal bacteremia: clinical and serologic studies of infants with mild illness. Am. J. Dis. Child. 131:1001-1004.
5. Bass, J. L., R. Nuss, K. A. Mehta, P. Morganelli, and L. Bennett. 1983. Recurrent meningococcemia associated with IgG2-subclass deficiency N. Engl. J. Med. 309:430.
6. Boslego, J., J. Garcia, C. Cruz, W. Zollinger, B. Brandt, S. Ruiz, M. Martinez, J. Arthur, P. Underwood, W. Silva, et al. 1995. Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Vaccine 13:821-829.
7. Burian, V., E. Gotschlich, P. Kuzemenska, and E. Svandova. 1977. Naturally occurring antibodies to Neisseria meningitidis. Bull. W. H. O. 55:653-657.
8. Castagliuolo, P. P., R. Nisini, I. Quinti, A. Fattorossi, and R. D'Amelio. 1986. Immunoglobulin deficiencies and meningococcal disease. Ann. Allergy 57: 68-70.
9. Claassen, I., J. Meylis, P. van der Ley, C. Peeters, H. Brons, J. Robert, D. Borsboom, A. van der Ark, I. van Straaten, P. Roholl, B. Kuipers, and J. Poolman. 1996. Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine. Vaccine 14:1001-1008.
10. de Moraes, J. C., B. A. Perkins, M. C. Camargo, N. T. Hidalgo, H. A. Barbosa, C. T. Sacchi, I. M. Landgraf, V. L. Gattas, H. D. G. Vasconcelos, I. M. Gral, et al. 1992. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet 340:1074-1078.
11. Frasch, C. E., and J. D. Robbins. 1978. Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model. J. Exp. Med. 147:629-644.
12. Goldblatt, D., M. W. Turner, and R. J. Levinsky. 1990. Branhamella cattarhalis: antigenic determinants and the development of the IgG subclass response in childhood. J. Infect. Dis. 162:1128-1135.
13. Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129:1307-1326.
14. Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. II. Development of natural immunity. J. Exp. Med. 129:1327-1348.
15. Granoff, D. M., S. K. Kelsey, H. A. Bijlmer, L. Van Alphen, J. Dankert, R. E. Mandrell, F. H. Azmi, and R. J. Scholten. 1995. Antibody responses to the capsular polysaccharide of Neisseria meningitidis serogroup B in patients with meningococcal disease. Clin. Diagn. Lab. Immunol. 2:574-582.
16. Griffiss, J. M. 1982. Epidemic meningococcal disease: synthesis of a hypothetical immunoepidemiologic model. Rev. Infect. Dis. 4:159-172.
17. Griffiss, J. M. 1995. Mechanisms of host immunity, p. 35-70. In K. Cartwright (ed.), Meningococcal disease. John Wiley & Sons, Chichester, United Kingdom.
18. Griffiss, J. M., B. L. Brandt, D. D. Broud, D. K. Goroff, and C. J. Baker. 1984. Immune response of infants and children to disseminated infections with Neisseria meningitidis. J. Infect. Dis. 150:71-79.
19. Guttormsen, H. K., L. M. Wetzler, and A. Naess. 1993. Humoral immune response to the class 3 outer membrane protein during the course of meningococcal disease. Infect. Immun. 61:4734-4742.
20. Guttormsen, H. K., L. M. Wetzler, and C. O. Solberg. 1994. Humoral immune response to class 1 outer membrane protein during the course of meningococcal disease. Infect. Immun. 62:1437-1443.
21. Harthug, S., E. Rosenqvist, E. A. Hoiby, T. W. Gedde-Dahl, and L. O. Froholm. 1986. Antibody response in group B meningococcal disease determined by enzyme-linked immunosorbent assay with serotype 15 outer membrane antigen. J. Clin. Microbiol. 24:947-953.
22. Holten, E. 1979. Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978. J. Clin. Microbiol. 9:186-188.
23. Idanpaan-Heikkila, I., E. A. Hoiby, P. Chattopadhyay, U. Airaksinen, T. M. Michaelsen, and E. Wedege. 1995. Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease. J. Med. Microbiol. 43:335-343.
24. Kasper, D. L., J. L. Winkelhake, B. L. Brandt, and M. S. Artenstein. 1973, Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis. J. Infect. Dis. 127:378-387.
25. Kristiansen, B. E., K. W. Lind, K. Mevold, B. Sorensen, L. O. Froholm, K. Bryn, T. Tjade, and K. Bovre. 1988. Meningococcal phenotypic and genotypic characteristics and human antibody levels. J. Clin. Microbiol. 26:1988-1992.
26. Mandrell, R. E., F. H. Azmi, and D. M. Granoff. 1995. Complement-mediated bactericidal activity of human antibodies to poly alpha 2→8 N-acetylneuraminic acid, the capsular polysaccharide of Neisseria meningitidis serogroup B. J. Infect. Dis. 172:1279-1289.
27. Mandrell, R. E., and W. D. Zollinger. 1982. Measurement of antibodies to meningococcal group B polysaccharide: low avidity binding and equilibrium binding constants. J. Immunol. 129:2172-2178.
28. Maslanka, S. E., L. L. Gheesling, D. E. Libutti, K. B. Donaldson, H. S. Harakeh, J. K. Dykes, F. F. Arhin, S. J. Devi, C. E. Frasch, J. C. Huang, P. Kriz-Kuzemenska, R. D. Lemmon, M. Lorange, C. C. Peelers, S. Quataert, J. Y. Tai, and G. M. Carlone. 1997. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. Gin. Diagn. Lab. Immunol. 4:155-167.
29. McGuinness, B. T., I. N. Clarke, P. R. Lambden, A. K. Barlow, J. T. Poolman, D. M. Jones, and J. E. Heckels. 1991. Point mutation in meningococcal por A gene associated with increased endemic disease. Lancet 337:514-517.
30. Milagres, L. G., A. P. Lemos, C. E. Meles, E. L. Silva, L. H. Ferreira, J. A. Souza, and G. M. Carlone. 1995. Antibody response after immunization of Brazilian children with serogroup C meningococcal polysaccharide noncovalently complexed with outer membrane proteins. Braz. J. Med. Biol. Res. 28:981-989.
31. Milagres, L. G., S. R. Ramos, C. T. Sacchi, C. E. Melles, V. S. Vieira, H. Sato, G. S. Brito, J. C. Moracs, and C. E. Frasch. 1994. Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy. Infect. Immun. 62:4419-4424.
32. Naess, L. M., E. Rosenqvist, E. A. Hoiby, and T. E. Michaelsen. 1996. Quantitation of IgG subclass antibody responses after immunization with a group B meningococcal outer membrane vesicle vaccine, using monoclonal mouse-human chimeric antibodies as standards. J. Immunol Methods 196: 41-49.
33. Nicholson, A., and I. H. Lepow. 1979. Host defense against Neisseria meningitidis requires a complement-dependent bactericidal activity. Science 205: 298-299.
34. Noah, N., and M. Connolly. 1996. Surveillance of bacterial meningitis in Europe 1995. King's European Meningitis Surveillance Unit, London, United Kingdom.
35. Noronha, C. P., C. J. Struchiner, and M. E. Halloran. 1995. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study. Int. J. Epidemiol. 24:1050-1057.
36. Peeters, C. C., H. C. Rumke, L. C. Sundermann, E. M. Rouppe van der Voort, J. Meulenbelt, M. Schuller, A. J. Kulpers, P. van der Ley, and J. T. Poolman. 1996. Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine 14:1009-1015.
37. Peltola, H., H. Makela, H. Kayhty, H. Jousimies, E. Herva, K. Hallstrom, A. Sivonen, O. V. Renkonen, O. Pettay, V. Karanko, P. Ahvonen, and S. Sarna. 1977. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N. Engl. J. Med. 297:686-691.
38. Perkins, B. A., K. Jonsdottir, H. Briem, E. Griffiths, B. D. Plikaytis, E. A. Hoiby, E. Rosenqvist, J. Holst, H. Nokleby, F. Sotolongo, G. Sierra, H. C. Campa, G. M. Carlone, D. Williams, J. Dykes, D. Kapczynski, E. Tikhomirov, J. D. Wenger, and C. V. Broome. 1998. Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland. J. Infect. Dis. 177:683-691.
39. Poolman, J. T. 1995. Development of a meningococcal vaccine. Infect. Agents Dis. 4:13-28.
40. Rautonen, N., J. Pelkonen, S. Sipinen, H. Kayhty, and O. Makela. 1986. Isotype concentrations of human antibodies to group A meningococcal polysaccharide. J. Immunol. 137:2670-2675.
41. Rijkers, G. T., E. A. M. Saunders, and B. J. M. Zegers. 1994. Anti-capsular polysaccharide antibody deficiency states. Immunodeficiency 5:1-21.
42. Rosenqvist, E., S. Harthug, L. O. Froholm, E. A. Hoiby, K. Bovre, and W. D. Zollinger. 1988. Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection. J. Clin. Microbiol. 26: 1543-1548.
43. Rosenqvist, E., E. A. Hoiby, G. Bjune, K. Bryn, O. Closs, B. Feiring, A. Klem, H. Nokleby, and L. O. Frolm. 1991. Human antibody responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine: results from ELISA studies. NIPH Ann. 14:169-179, 180-181.
44. Rosenqvist, E., E. A. Hoiby, E. Wedege, K. Bryn, J. Kolberg, A. Klem, E. Ronnild, G. Bjune, and H. Nokleby. 1995. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect. Immun. 63:4642-4652.
45. Rosenstein, N., O. Leyine. J. P. Taylor, D. Evans, B. D. Plikaytis, J. D. Wenger, and B. A. Perkins. 1998. Efficacy of meningococcal vaccine and barriers to vaccination. JAMA 279:435-439.
46. Shackleford, P. G., D. M. Granoff, S. H. Polmar, M. G. Scott, M. C. Goskowicz, J. V. Madaserry, and M. H. Nahm. 1990. Subnormal serum concentration of IgG2 in children with frequent infections associated with varied patterns of immunologic dysfunction. J. Pediatr. 116:529-538.
47. Sierra, G. V., H. C. Campa, N. M. Varcacel, I. L. Garcia, P. L. Izquierdo, P. F. Sotolongo, G. V. Casanueva, C. O. Rico, C. R. Rodriguez, and M. H. Terry. 1991. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann. 14:195-207, 208-210.
48. Sjursen, H., E. Wedege, E. Rosenqvist, A. Naess, A. Halstensen, R. Matre, and C. O. Solberg. 1990. IgG subclass antibodies to serogroup B meningococcal outer membrane antigens following infection and vaccination. APMIS 98:1061-1069.
49. Skevakis, L., C. E. Frasch, J. M. Zahradnik, and R. Dolin. 1984. Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis. J. Infect. Dis. 149:387-396.
50. Tappero, J., R Lagos, A. Maldonado, P. Herrera, L. Gheesling, D. Williams, G. Carlone, B. Plikaytis, H. Nokleby, J. Holst, G. Sierra, and B. Perkins. 1996. Serum bactericidal activity elicited by two outer membrane protein serogroup B meningococcal vaccines among infants, pre-school children, and adults in Santiago, Chile. Neisseria '96, 110th International Pathogenic Neisseria Conference, Baltimore, Md.
51. Trollfors, B., T. Lagergard, B. A. Claesson, E. Thornberg, J. Martinell, and R. Schneerson. 1992. Characterisation of the serum antibody response to the capsular polysaccharide of Haemophilus influenzae type b in children with invasive infections. J. Infect. Dis. 166:1335-1339.
52. Van Der Ley, P., and J. T. Poolman. 1992. Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane protein. Infect. Immun. 60:3156-3161.
53. van der Ley, P., J. van der Biezen, P. Hohenstein, C. Peeters, and J. T. Poolman. 1993. Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis. Infect. Immun. 61:4217-4224.
54. van der Ley, P., J. van der Biezen, and J. T. Poolman. 1995. Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccine. Vaccine 13:401-407.
55. Wahdan, M. H., S. A. Sallam, M. N. Hassan, A. Abdel Gawad, A. S. Rakha, J. E. Sippel, R. Hablas, W. R. Sanborn, N. M. Kassem, S. M. Riad, and B. Cvjetanovic. 1977. A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria. Bull W. H. O. 55:645-651.
56. Wyle, F. A., M. S. Artenstein, B. L. Brandt, E. C. Tramont, D. L. Kasper, P. L. Altieri, S. L. Berman, and J. P. Lowenthal. 1972. Immunologic response of man to group B meningococcal polysaccharide vaccines. J. Infect. Dis. 126:514-521.
57. Zollinger, W. D., and R. E. Mandrell. 1983. Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide. Infect. Immun. 40:257-264.
58. Zollinger, W. D., R. E. Mandrell, P. Altieri, S. Berman, J. Lowenthal, and M. S. Artenstein. 1978. Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humans. J. Infect. Dis. 137:728-739.
59. Zollinger, W. D., R. E. Mandrell, J. M. Griffiss, P. Altieri, and S. Berman. 1979. Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man. J. Clin. Investig. 63:836-848.
60. Zorgani, A. A., V. S. James, J. Stewart, C. C. Blackwell, R. A. Elton, and D. M. Weir. 1996. Serum bactericidal activity in a secondary school population following an outbreak of meningococcal disease: effects of carriage and secretor status. FEMS Immunol. Med. Microbiol. 14:73-81.